Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Review
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 18,399 | Dovepress* | 13,090+ | 1,752 | 14,842 | |
| PubMed Central* | 5,309 | 1,033 | 6,342 | ||
| Totals | 18,399 | 2,785 | 21,184 | ||
| *Since 19 June 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 0 | 0 | 5 |
View citations on PubMed Central and Google Scholar